{"id":"placebo-for-omeprazole","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL1503","moleculeType":"Small molecule","molecularWeight":"345.42"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"As a placebo, it does not interact with any biological molecules or systems. It is used as a control in clinical trials to compare the efficacy of active treatments.","oneSentence":"Placebo is a dummy treatment with no active pharmacological effect.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:51:25.140Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Symptomatic gastroesophageal reflux disease (GERD)"}]},"trialDetails":[{"nctId":"NCT06562907","phase":"PHASE1","title":"Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM)","status":"RECRUITING","sponsor":"Gilead Sciences","startDate":"2024-08-28","conditions":"Weight Management","enrollment":134},{"nctId":"NCT06566794","phase":"NA","title":"KF2022#4-trial: Effects of a Beta Blocker and NSAID on CYP Mediated Drug Metabolism","status":"COMPLETED","sponsor":"Helsinki University Central Hospital","startDate":"2024-08-22","conditions":"Drug Interaction","enrollment":12},{"nctId":"NCT07142486","phase":"NA","title":"Effects of Omeprazole Ingestion on Postprandial Amino Acid Concentrations in Response to a Mixed Meal","status":"RECRUITING","sponsor":"McGill University","startDate":"2025-09-01","conditions":"Digestive Health, Gastrointestinal Health","enrollment":4},{"nctId":"NCT06393868","phase":"PHASE3","title":"Reducing Gastrointestinal Bleeding With Proton Pump Inhibitor Therapy in Acute Venous Thromboembolism","status":"RECRUITING","sponsor":"Ottawa Hospital Research Institute","startDate":"2024-11-06","conditions":"Venous Thromboembolism, Gastro Intestinal Bleeding, Blood Clot","enrollment":360},{"nctId":"NCT05517928","phase":"NA","title":"A Study to Evaluate the Impact of Lactobacillus Rhamnosus GG on Proton Pump Inhibitor-Induced Gut Dysbiosis","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2023-03-03","conditions":"Healthy","enrollment":30},{"nctId":"NCT07104318","phase":"PHASE3","title":"Personalized vs Standard of Care Treatment for Helicobacter Pylori Eradication Among Veterans","status":"NOT_YET_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2026-04-01","conditions":"Helicobacter Pylori","enrollment":360},{"nctId":"NCT06999577","phase":"PHASE4","title":"The Mechanism Versus PPI Trial","status":"RECRUITING","sponsor":"University of California, San Diego","startDate":"2025-06-04","conditions":"Laryngopharyngeal Reflux, Cough, Throat Clearing","enrollment":160},{"nctId":"NCT06279234","phase":"PHASE1","title":"A Study to Learn How Different Amounts of PF-06954522 Are Tolerated and Act in Adults With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Pfizer","startDate":"2024-02-20","conditions":"Type 2 Diabetes Mellitus (T2DM), Obesity","enrollment":50},{"nctId":"NCT04448028","phase":"PHASE4","title":"Stop of Proton-pump Inhibitor Treatment in Patients With Liver Cirrhosis - a Double-blind, Placebo-controlled Trial","status":"RECRUITING","sponsor":"Universitätsklinikum Hamburg-Eppendorf","startDate":"2021-04-22","conditions":"Liver Cirrhosis","enrollment":476},{"nctId":"NCT03267680","phase":"PHASE2","title":"IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3","status":"TERMINATED","sponsor":"University of Southern California","startDate":"2017-11-08","conditions":"Cervical Squamous Cell Carcinoma In Situ, Vulvar High Grade Squamous Intraepithelial Lesion","enrollment":10},{"nctId":"NCT06903585","phase":"PHASE2","title":"Non Steroidal Anti-inflammatory Drugs in the Prevention of Bone Pain Flares After Palliative Radiotherapy","status":"NOT_YET_RECRUITING","sponsor":"American University of Beirut Medical Center","startDate":"2025-04","conditions":"Bone Pain Flare, Bone Metastasis","enrollment":385},{"nctId":"NCT06546111","phase":"PHASE1, PHASE2","title":"Clinical Study to Evaluate the Possible Efficacy and Safety of Diosmin and Hesperidin Combined Therapy in Patients With Helicobacter Pylori Infection","status":"RECRUITING","sponsor":"Sadat City University","startDate":"2024-10-01","conditions":"Helicobacter Pylori Infection","enrollment":46},{"nctId":"NCT03551691","phase":"PHASE2","title":"Proton Pump Inhibitors (PPI) and Fat Absorption in Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (EPI)","status":"COMPLETED","sponsor":"Children's Hospital of Philadelphia","startDate":"2018-08-07","conditions":"Pancreatic Insufficiency, Cystic Fibrosis","enrollment":19},{"nctId":"NCT04069286","phase":"PHASE3","title":"EFFICACY OF ORAL AROEIRA (Schinus Terebinthifolia Raddi) COMPARED TO OMEPRAZOLE IN DYSPEPPSIA","status":"NOT_YET_RECRUITING","sponsor":"Infan Industria Quimica Farmaceutica Nacional","startDate":"2025-03","conditions":"Dyspepsia","enrollment":474},{"nctId":"NCT05664685","phase":"PHASE4","title":"Optimized Bismuth Quadruple Therapy vs Triple Standard Therapy for Helicobacter Pylori Eradication","status":"COMPLETED","sponsor":"Pontificia Universidad Catolica de Chile","startDate":"2022-10-17","conditions":"Helicobacter Pylori Infection","enrollment":127},{"nctId":"NCT01216293","phase":"PHASE1","title":"Effect of Dexlansoprazole on Bone Homeostasis","status":"COMPLETED","sponsor":"Takeda","startDate":"2010-11-01","conditions":"Homeostasis, Bone and Bones","enrollment":115},{"nctId":"NCT03452865","phase":"PHASE3","title":"Esomeprazole to Reduce Organ Failure in Sepsis","status":"COMPLETED","sponsor":"Università Vita-Salute San Raffaele","startDate":"2020-01-28","conditions":"Sepsis, Septic Shock","enrollment":300},{"nctId":"NCT05577468","phase":"PHASE3","title":"Efficacy and Safety of Tegoprazan Versus Esomeprazole-containing Bismuth Quadruple Therapy for Eradication of Helicobacter Pylori","status":"COMPLETED","sponsor":"Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.","startDate":"2022-10-30","conditions":"Helicobacter Pylori Infection","enrollment":561},{"nctId":"NCT02407119","phase":"PHASE3","title":"Effects of H. Pylori Eradication on the Gastric Preneoplastic Lesion and Neoplasm After ESD","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Center, Korea","startDate":"2003-06","conditions":"Helicobacter Pylori Infection, Early Gastric Cancer, Endoscopic Resection","enrollment":470},{"nctId":"NCT03033342","phase":"PHASE1","title":"Single Dose and Multiple Dose Escalation Trial of an Oral Formulation of MRX-4","status":"COMPLETED","sponsor":"MicuRx","startDate":"2016-08-02","conditions":"Safety","enrollment":122},{"nctId":"NCT01133951","phase":"NA","title":"Helicobacter Pylori Eradication to Prevent Gastric Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jie-Jun Wang","startDate":"2010-06","conditions":"Helicobacter Infections, Stomach Neoplasms","enrollment":3000},{"nctId":"NCT02476097","phase":"PHASE4","title":"PROGRESSive Withdrawal Esomeprazole and Acid-related Symptoms","status":"UNKNOWN","sponsor":"Victoria Rollason","startDate":"2015-06","conditions":"Stomach Diseases","enrollment":58},{"nctId":"NCT05841394","phase":"PHASE3","title":"A Multi-center, Double-blinding, Parallel and Positive-controlled Phase III Clinical Trial for Efficacy and Safety Evaluation of Ilaprazole Sodium for Injection on Prevention of Stress Ulcer Bleeding","status":"COMPLETED","sponsor":"Livzon Pharmaceutical Group Inc.","startDate":"2021-07-16","conditions":"Stress Ulcer Bleeding","enrollment":449},{"nctId":"NCT02081404","phase":"NA","title":"Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective Study","status":"COMPLETED","sponsor":"Midwest Biomedical Research Foundation","startDate":"2009-03-01","conditions":"Non-erosive Reflux Disease","enrollment":98},{"nctId":"NCT02013427","phase":"PHASE4","title":"Placebo In Chronic Back Pain - Double-Blind Randomized Control Trial","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2014-10","conditions":"Chronic Low Back Pain","enrollment":82},{"nctId":"NCT02986334","phase":"PHASE4","title":"Placebo In Chronic Back Pain (Phase 2)","status":"COMPLETED","sponsor":"Apkar Apkarian","startDate":"2016-08","conditions":"Chronic Low Back Pain","enrollment":94},{"nctId":"NCT04178187","phase":"NA","title":"The Role of Probiotics in the Eradication of Helicobacter Pylori","status":"COMPLETED","sponsor":"Evangelismos Hospital","startDate":"2019-10-02","conditions":"Helicobacter Pylori Infection","enrollment":660},{"nctId":"NCT04198948","phase":"PHASE1","title":"Interaction Between Omeprazole and Gliclazide in CYP2C19 Normal/ Ultrarapid Metabolisers","status":"COMPLETED","sponsor":"University of Sarajevo","startDate":"2019-03-04","conditions":"Diabetes Mellitus, Type 2","enrollment":15},{"nctId":"NCT02475369","phase":"PHASE4","title":"Pancreatic Enzyme Supplementation for Celiac Disease","status":"TERMINATED","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2015-05","conditions":"Celiac Disease","enrollment":21},{"nctId":"NCT00978016","phase":"PHASE2","title":"A Study to Evaluate the Efficacy and Safety of Arbaclofen Placarbil (XP19986) as Adjunctive Therapy in Subjects With Gastroesophageal Reflux Disease (GERD)","status":"COMPLETED","sponsor":"XenoPort, Inc.","startDate":"2009-09","conditions":"Gastroesophageal Reflux Disease","enrollment":460},{"nctId":"NCT00640809","phase":"PHASE4","title":"Comparison of Small Bowel Lesions Associated With Celecoxib Versus Ibuprofen Plus Omeprazole","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2003-10","conditions":"Bowel Diseases, Inflammatory","enrollment":408},{"nctId":"NCT04527562","phase":"NA","title":"Colchicine in Moderate Symptomatic COVID-19 Patients","status":"COMPLETED","sponsor":"Dhaka Medical College","startDate":"2020-07-14","conditions":"Covid19","enrollment":299},{"nctId":"NCT03086070","phase":"PHASE4","title":"Omeprazole 20 mg in Patients With Laryngopharyngeal reflux and Comorbid Chronic Rhinosinusitis","status":"COMPLETED","sponsor":"Children's Hospital Srebrnjak","startDate":"2010-01-01","conditions":"Laryngopharyngeal Reflux, Chronic Rhinosinusitis (Diagnosis)","enrollment":60},{"nctId":"NCT04080726","phase":"PHASE3","title":"Efficacy and Safety of HIP1601 Capsule","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2018-10-25","conditions":"Erosive Gastroesophageal Reflux Disease","enrollment":213},{"nctId":"NCT03736369","phase":"PHASE3","title":"Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 3)","status":"COMPLETED","sponsor":"Daewoong Pharmaceutical Co. LTD.","startDate":"2018-12-13","conditions":"Erosive Esophagitis","enrollment":263},{"nctId":"NCT03615677","phase":"PHASE3","title":"Efficacy and Safety of LXI-15028 Comparing With Esomeprazole in the Treatment of Erosive Esophagitis","status":"COMPLETED","sponsor":"Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.","startDate":"2018-10-24","conditions":"Erosive Esophagitis (EE)","enrollment":261},{"nctId":"NCT00719160","phase":"PHASE4","title":"The Effect of Protein on Calcium Absorption and Gastric Acid Production","status":"COMPLETED","sponsor":"Yale University","startDate":"2005-01","conditions":"Osteoporosis","enrollment":12},{"nctId":"NCT04142762","phase":"PHASE1","title":"A Study to Assess CYP3A4 Modulator, Oral Contraceptive, and pH Modifier Drug Interactions for ABI-H2158 in Healthy Adults","status":"COMPLETED","sponsor":"Assembly Biosciences","startDate":"2019-10-18","conditions":"Chronic Hepatitis B","enrollment":80},{"nctId":"NCT02743949","phase":"PHASE2","title":"Comparison of Vonoprazan to Esomeprazole in Participants With Symptomatic GERD Who Responded Partially to a High Dose of Proton Pump Inhibitor (PPI)","status":"COMPLETED","sponsor":"Takeda","startDate":"2016-07-14","conditions":"Gastroesophageal Reflux","enrollment":256},{"nctId":"NCT01265550","phase":"PHASE3","title":"A Randomized Trial of Medical and Surgical Treatments for Patients With GERD Symptoms That Are Refractory to Proton Pump Inhibitors","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2012-08-13","conditions":"GERD","enrollment":366},{"nctId":"NCT00339768","phase":"PHASE3","title":"A Randomized Multi-Intervention Trial to Inhibit Precancerous Gastric Lesions in Lingu, Shandong Province","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"1995-07-01","conditions":"Precancerous Gastric Lesions","enrollment":3411},{"nctId":"NCT02637557","phase":"PHASE2","title":"A Trial of IW-3718 for 8 Weeks in Patients With Symptomatic Gastroesophageal Reflux Disease (GERD)","status":"COMPLETED","sponsor":"Ironwood Pharmaceuticals, Inc.","startDate":"2016-03-01","conditions":"Gastroesophageal Reflux Disease","enrollment":282},{"nctId":"NCT01980095","phase":"PHASE3","title":"ERADICATE Hp - Treating Helicobacter Pylori With RHB-105","status":"COMPLETED","sponsor":"RedHill Biopharma Limited","startDate":"2013-11","conditions":"Dyspepsia, Helicobacter Pylori Infection","enrollment":119},{"nctId":"NCT03291249","phase":"PHASE2","title":"Assessment of the Safety of Foralumab, an Oral Anti-CD3 Antibody, in Patients With NASH and T2DM","status":"WITHDRAWN","sponsor":"Tiziana Life Sciences LTD","startDate":"2017-12-01","conditions":"NASH - Nonalcoholic Steatohepatitis, NAFLD, T2DM (Type 2 Diabetes Mellitus)","enrollment":""},{"nctId":"NCT02262169","phase":"PHASE3","title":"DLBS2411 Treatment for Ulcer Healing in Non-Bleeding Peptic Ulcers","status":"TERMINATED","sponsor":"Dexa Medica Group","startDate":"2014-10","conditions":"Non-Bleeding Peptic Ulcers","enrollment":32},{"nctId":"NCT00745849","phase":"NA","title":"Efficacy of Esomeprazole for Non-Allergic Rhinitis: A Double-blind, Placebo Controlled Trial","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2005-06","conditions":"Vasomotor Rhinitis","enrollment":43},{"nctId":"NCT01399047","phase":"PHASE2","title":"Cellcept for Treatment of Juvenile Neuronal Ceroid Lipofuscinosis","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2011-07","conditions":"Juvenile Neuronal Ceroid Lipofuscinosis","enrollment":19},{"nctId":"NCT01670552","phase":"PHASE3","title":"Evaluation of Two Therapies for the Treatment of Osteoarticular Inflammation in Dyspeptic Patients","status":"COMPLETED","sponsor":"EMS","startDate":"2016-02-17","conditions":"Acute and Chronic Inflammation, Dyspepsia","enrollment":490},{"nctId":"NCT00951431","phase":"PHASE4","title":"Gastric Functions & Proton Pump Inhibitor( PPI) Study","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2009-12-03","conditions":"Functional Dyspepsia","enrollment":155},{"nctId":"NCT01349413","phase":"PHASE4","title":"BRAVO Study for Functional Dyspepsia","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2011-08-24","conditions":"Dyspepsia, Gastroesophageal Reflux","enrollment":130},{"nctId":"NCT03717740","phase":"PHASE3","title":"Esomeprazole for the Prevention of Preeclampsia","status":"UNKNOWN","sponsor":"Aswan University Hospital","startDate":"2018-12-01","conditions":"Pre-Eclampsia","enrollment":1000},{"nctId":"NCT03781596","phase":"PHASE4","title":"EoE RCT Fluticasone and Omeprazole vs Fluticasone Alone","status":"UNKNOWN","sponsor":"Claire Daniels","startDate":"2018-10-02","conditions":"Eosinophilic Esophagitis","enrollment":100},{"nctId":"NCT00206440","phase":"PHASE3","title":"Nexium Study To Suppress Nausea During Chemotherapy","status":"TERMINATED","sponsor":"Baylor Breast Care Center","startDate":"2005-08","conditions":"Nausea","enrollment":43},{"nctId":"NCT03662269","phase":"PHASE3","title":"Indomethacin for Refractory Chronic Cough","status":"UNKNOWN","sponsor":"The First Affiliated Hospital of Guangzhou Medical University","startDate":"2018-10-22","conditions":"Refractory Chronic Cough","enrollment":84},{"nctId":"NCT01777854","phase":"PHASE4","title":"Anti-reflux Control to Decrease Post Tonsillectomy Pain","status":"TERMINATED","sponsor":"Ascension Health","startDate":"2013-01","conditions":"Laryngopharyngeal Reflux, Throat Pain","enrollment":6},{"nctId":"NCT03205228","phase":"PHASE3","title":"Treatment in Patients With Globus: Psychoeducation, Anxiolytics or Proton Pump Inhibitors","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2017-07-07","conditions":"Globus","enrollment":40},{"nctId":"NCT02586636","phase":"PHASE4","title":"Impact of OCT1 on Metformin Tolerance","status":"COMPLETED","sponsor":"NHS Tayside","startDate":"2016-03","conditions":"Tolerance","enrollment":61},{"nctId":"NCT01661101","phase":"PHASE3","title":"Management of Myocardial Injury After Noncardiac Surgery Trial","status":"COMPLETED","sponsor":"Population Health Research Institute","startDate":"2013-01","conditions":"Myocardial Injury After Noncardiac Surgery (MINS)","enrollment":1754},{"nctId":"NCT00404534","phase":"PHASE3","title":"Helicobacter Eradication Relief of Dyspeptic Symptoms","status":"COMPLETED","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2006-10","conditions":"Functional Dyspepsia","enrollment":407},{"nctId":"NCT03444831","phase":"PHASE4","title":"Buspirone Plus Omeprazole for Functional Dyspepsia","status":"COMPLETED","sponsor":"Isfahan University of Medical Sciences","startDate":"2016-03-01","conditions":"Dyspepsia","enrollment":70},{"nctId":"NCT03388463","phase":"NA","title":"Single Dose Omeprazole Versus High Dose in High-risk Critically Ill Patients.","status":"COMPLETED","sponsor":"Menoufia University","startDate":"2016-05-11","conditions":"Critical Illness","enrollment":110},{"nctId":"NCT02085018","phase":"PHASE2","title":"Pilot Trial Of Omeprazole in Idiopathic Pulmonary Fibrosis (IPF)","status":"COMPLETED","sponsor":"Newcastle-upon-Tyne Hospitals NHS Trust","startDate":"2014-03-28","conditions":"Idiopathic Pulmonary Fibrosis","enrollment":45},{"nctId":"NCT03146325","phase":"PHASE4","title":"Helicobacter Pylori and Body Iron in Adults","status":"WITHDRAWN","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2012-11","conditions":"Helicobacter Pylori Infection","enrollment":""},{"nctId":"NCT02757144","phase":"PHASE1","title":"Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Male Volunteers","status":"COMPLETED","sponsor":"Daewoong Pharmaceutical Co. LTD.","startDate":"2016-03","conditions":"Healthy","enrollment":120},{"nctId":"NCT01878526","phase":"PHASE3","title":"Gastroesophageal Reflux Treatment in Scleroderma","status":"COMPLETED","sponsor":"Khon Kaen University","startDate":"2013-06","conditions":"Gastroesophageal Reflux Disease, Systemic Sclerosis, Scleroderma","enrollment":80},{"nctId":"NCT00559364","phase":"PHASE3","title":"Safety and Efficacy Study of Viokase® 16 for the Correction of Steatorrhea","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2007-11","conditions":"Exocrine Pancreatic Insufficiency, Chronic Pancreatitis, Pancreatectomy","enrollment":50},{"nctId":"NCT02984930","phase":"NA","title":"Effect of Proton Pump Inhibitor and Mosapride on Acid Pocket in Gastroesophageal Reflux Disease","status":"UNKNOWN","sponsor":"Gangnam Severance Hospital","startDate":"2016-12","conditions":"Gastroesophageal Reflux Disease","enrollment":30},{"nctId":"NCT00361985","phase":"PHASE4","title":"Study of Proton Pump Inhibitors (PPI) to Prevent Strictures After Gastric Bypass Surgery","status":"WITHDRAWN","sponsor":"Weill Medical College of Cornell University","startDate":"2008-01","conditions":"Anastomotic Stricture, Morbid Obesity","enrollment":""},{"nctId":"NCT01873079","phase":"PHASE3","title":"PPI for Prevention of Post-sphincterotomy Bleeding","status":"COMPLETED","sponsor":"The University of Hong Kong","startDate":"2013-04","conditions":"Bleeding, ERCP","enrollment":185},{"nctId":"NCT02703896","phase":"PHASE4","title":"Prophylaxis for Aspiration of Gastric Contents.","status":"COMPLETED","sponsor":"King Saud University","startDate":"2012-01","conditions":"Pulmonary Aspiration of Gastric Contents","enrollment":1920},{"nctId":"NCT00444236","phase":"PHASE1","title":"Effect of Acid Reflux on Respiratory Physiology During Exercise in Athletes With GER-Response to Acid Suppression","status":"TERMINATED","sponsor":"University of Utah","startDate":"2007-04","conditions":"Exercise Triggered Asthma, Gastroesophageal Reflux","enrollment":31},{"nctId":"NCT02134405","phase":"PHASE4","title":"Rebamipide in Combination With Esomeprazole in the Management of Asian Patients With Functional Dyspepsia","status":"UNKNOWN","sponsor":"University of Malaya","startDate":"2014-08","conditions":"Dyspepsia","enrollment":200},{"nctId":"NCT02620696","phase":"PHASE1","title":"Effect of Netazepide on Omeprazole-induced Changes in Chromogranin A and Gastrin","status":"COMPLETED","sponsor":"Trio Medicines Ltd.","startDate":"2009-11","conditions":"ECL-cell Hyperplasia, Parietal-cell Hyperplasia, Rebound Hyperacidity","enrollment":48},{"nctId":"NCT01269333","phase":"PHASE1","title":"Impact of Omeprazole and Fluvoxamine on Platelet Response to Clopidogrel","status":"COMPLETED","sponsor":"Hadassah Medical Organization","startDate":"2011-01","conditions":"Drug Interaction of Clopidogrel","enrollment":15},{"nctId":"NCT01593592","phase":"NA","title":"Lactobacillus Reuteri in Management of Helicobacter Pylori Infection in Dyspeptic Patients","status":"COMPLETED","sponsor":"Zagazig University","startDate":"2012-06","conditions":"Helicobacter Pylori Infection","enrollment":70},{"nctId":"NCT01142245","phase":"PHASE3","title":"Effect of IV and Oral Esomeprazole in Prevention of Recurrent Bleeding From Peptic Ulcers After Endoscopic Therapy","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2008-01","conditions":"Peptic Ulcer, Bleeding","enrollment":263},{"nctId":"NCT01782560","phase":"PHASE1","title":"Laryngomalacia Study","status":"WITHDRAWN","sponsor":"Children's & Women's Health Centre of British Columbia","startDate":"2013-02","conditions":"Laryngomalacia","enrollment":""},{"nctId":"NCT02355236","phase":"PHASE4","title":"Gastro-protective Effect and Pain Relief Effect of Naxozol Compared to Celecoxib in Patients With Osteoarthritis","status":"UNKNOWN","sponsor":"Severance Hospital","startDate":"2015-02","conditions":"Osteoarthritis","enrollment":106},{"nctId":"NCT01077076","phase":"PHASE3","title":"Pharmacodynamic Study Comparing the Effects of Two Different Forms of Omeprazole (P07812) (COMPLETED)","status":"COMPLETED","sponsor":"Bayer","startDate":"2008-12","conditions":"Intragastric Acidity","enrollment":30},{"nctId":"NCT02288078","phase":"PHASE2","title":"Oral Steroids for Regorafenib-induced Fatigue/Malaise in Unresectable mCRC (KSCC1402/HGCSG1402)","status":"UNKNOWN","sponsor":"Clinical Research Support Center Kyush","startDate":"2014-10","conditions":"Rectal Cancer","enrollment":74},{"nctId":"NCT01750437","phase":"PHASE2","title":"Phase 2 Clinical Trial to Investigate the Safety, Tolerability and Efficacy of YH1885L in Patients With Non-erosive Reflux Disease(NERD)","status":"COMPLETED","sponsor":"Yuhan Corporation","startDate":"2013-01","conditions":"Non-erosive Reflux Disease","enrollment":149},{"nctId":"NCT00468559","phase":"PHASE3","title":"Phase 3/Safety & Efficacy of Esomeprazole in Infants","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2007-04","conditions":"Gastroesophageal Reflux Disease (GERD)","enrollment":98},{"nctId":"NCT00464308","phase":"PHASE4","title":"A Study to Compare the Number of Patients With Gastro-Oesophageal Reflux Disease (GORD) Achieving Heartburn and Regurgitation Symptom Resolution After Treatment With Either Rabeprazole Sodium 20mg, Esomeprazole 20mg or Esomeprazole 40mg","status":"COMPLETED","sponsor":"Janssen-Cilag Pty Ltd","startDate":"2006-11","conditions":"Gastro-oesophageal Reflux","enrollment":1392},{"nctId":"NCT01456728","phase":"PHASE3","title":"Lactobacillus Reuteri ProGastria in Helicobacter Pylori-infected Adult Subjects on Proton Pump Inhibitors","status":"COMPLETED","sponsor":"St Marina University Hospital, Varna, Bulgaria","startDate":"2011-01","conditions":"Helicobacter Pylori Infection","enrollment":56},{"nctId":"NCT00567658","phase":"PHASE3","title":"Effect of Acid Suppression With Esomeprazole on Vocal Cord Granulomas","status":"WITHDRAWN","sponsor":"Vanderbilt University","startDate":"2008-02","conditions":"Larynx Disease","enrollment":""},{"nctId":"NCT01142128","phase":"PHASE1","title":"Viokase 16, Viokase16 Plus Nexium and Nexium Alone","status":"TERMINATED","sponsor":"University of Florida","startDate":"2009-02","conditions":"Chronic Pancreatitis","enrollment":12},{"nctId":"NCT00069823","phase":"PHASE3","title":"Study of Acid Reflux in Asthma","status":"COMPLETED","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2003-09","conditions":"Asthma, Lung Diseases, Lung Diseases, Obstructive","enrollment":403},{"nctId":"NCT01069939","phase":"PHASE3","title":"Comparative Efficacy & Safety Study of D961H Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With Low-dose Aspirin","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2010-02","conditions":"Prevention","enrollment":427},{"nctId":"NCT00989300","phase":"PHASE1","title":"Influence of Rabeprazole on the Magnitude of the Antiplatelet Action of Clopidogrel","status":"COMPLETED","sponsor":"Janssen Cilag S.A.S.","startDate":"2009-11","conditions":"Healthy","enrollment":39},{"nctId":"NCT01599858","phase":"PHASE1","title":"Effect of Repeated Doses of YF476, Omeprazole and Placebo on Stomach Acidity in Healthy Volunteers","status":"COMPLETED","sponsor":"Trio Medicines Ltd.","startDate":"1996-08","conditions":"Reflux Oesophagitis","enrollment":49},{"nctId":"NCT01269788","phase":"PHASE2, PHASE3","title":"Comparing Omeprazole With Fluoxetine for Treatment of Non Erosive Reflux Disease and Its Subgroups: a Double-blind Placebo-controlled Clinical Trial","status":"COMPLETED","sponsor":"Tehran University of Medical Sciences","startDate":"2010-08","conditions":"Non-erosive Reflux Disease","enrollment":144},{"nctId":"NCT00287339","phase":"PHASE4","title":"The Utility of Nexium in Chronic Cough and Reflux Disease","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2005-09","conditions":"Cough, GERD","enrollment":40},{"nctId":"NCT01459419","phase":"PHASE2","title":"Oral Administration of Anti-CD3 Monoclonal Antibody in Non-responder Genotype-I Chronic Hepatitis C Subjects","status":"UNKNOWN","sponsor":"Inspira Medical AB","startDate":"2011-11","conditions":"Chronic Hepatitis C","enrollment":36},{"nctId":"NCT00641004","phase":"PHASE4","title":"Randomized Double-Blind Clinical Trial of Rebamipide vs Esomeprazole in the Treatment of NSAID-induced Gastropathy","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical, Inc., Philippines","startDate":"2008-04","conditions":"NSAID Induced Gastropathy","enrollment":30},{"nctId":"NCT00730665","phase":"PHASE2","title":"Efficacy And Safety Of PF-00885706 For The Relief Of Symptoms In Subjects With Gastro-esophageal Reflux Disease (GERD)","status":"TERMINATED","sponsor":"Pfizer","startDate":"2008-01","conditions":"Gastroesophageal Reflux Disease","enrollment":81},{"nctId":"NCT01205087","phase":"PHASE2","title":"Safety and Efficacy of Oral Administration of Anti-CD3 Monoclonal Antibody (mAb)in Patients With the Metabolic Syndrome","status":"COMPLETED","sponsor":"Hadassah Medical Organization","startDate":"2010-09","conditions":"Nonalcoholic Steatohepatitis","enrollment":36},{"nctId":"NCT00251979","phase":"PHASE3","title":"A Study to Prevent Rebleeding After Initial Successful Primary Endoscopic Haemostasis of a Bleeding Peptic Ulcer","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2005-10","conditions":"Gastrointestinal Hemorrhage","enrollment":1312},{"nctId":"NCT00786695","phase":"NA","title":"Study Using Esomeprazole as a Diagnostic Test for GERD in Patients With NCCP","status":"COMPLETED","sponsor":"National University Hospital, Singapore","startDate":"2006-05","conditions":"Gastroesophageal Reflux Disease","enrollment":60},{"nctId":"NCT00629928","phase":"PHASE3","title":"Ulcer Prevention II","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2001-02","conditions":"NSAID Associated Gastric Ulcers","enrollment":800},{"nctId":"NCT00251992","phase":"PHASE3","title":"Nexium Dyspepsia/AST","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2002-12","conditions":"Gastrointestinal Disease, Signs and Symptoms, Digestive, Dyspepsia","enrollment":1200}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":644,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo (for Omeprazole)","genericName":"Placebo (for Omeprazole)","companyName":"Population Health Research Institute","companyId":"population-health-research-institute","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Placebo (for Omeprazole) is a small molecule that functions as a potassium-transporting ATPase inhibitor. It is used to treat conditions such as Erosive Esophagitis, Dyspepsia, Helicobacter Pylori Infection, Chest Pain, and Gastroesophageal Reflux.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}